Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Curcio

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Angiogenesis|March 20, 2012
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumorsMaddalena Arigoni, Giuseppina Barutello, Stefania Lanzardo, et al.
Current Biology : CB|December 5, 2006
WIP regulates the stability and localization of WASP to podosomes in migrating dendritic cellsHsiu-Chuan Chou, Inés M Antón, Mark R Holt, et al.
Cancer Immunology Research|October 18, 2018
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast CancerCaterina Bartolacci, Cristina Andreani, Claudia Curcio, et al.
International Journal of Nanomedicine|March 5, 2026
Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor MicroenvironmentAntonino Di Lorenzo, Chiara Romiti, Alessandro Amaolo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2006
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growthLars Holmgren, Elena Ambrosino, Olivier Birot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunityMichela Spadaro, Elena Ambrosino, Manuela Iezzi, et al.
Oncoimmunology|July 9, 2015
Antitumor immunization of mothers delays tumor development in cancer-prone offspringGiuseppina Barutello, Claudia Curcio, Michela Spadaro, et al.
Oncotarget|December 10, 2017
Endogenous glutamine decrease is associated with pancreatic cancer progressionCecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, et al.
Journal of Cellular and Molecular Medicine|October 13, 2009
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathwayMarta Coscia, Elena Quaglino, Manuela Iezzi, et al.
The Journal of Clinical Investigation|April 17, 2003
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomasClaudia Curcio, Emma Di Carlo, Raphael Clynes, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Angiogenesis|March 20, 2012
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumorsMaddalena Arigoni, Giuseppina Barutello, Stefania Lanzardo, et al.
Current Biology : CB|December 5, 2006
WIP regulates the stability and localization of WASP to podosomes in migrating dendritic cellsHsiu-Chuan Chou, Inés M Antón, Mark R Holt, et al.
Cancer Immunology Research|October 18, 2018
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast CancerCaterina Bartolacci, Cristina Andreani, Claudia Curcio, et al.
International Journal of Nanomedicine|March 5, 2026
Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor MicroenvironmentAntonino Di Lorenzo, Chiara Romiti, Alessandro Amaolo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2006
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growthLars Holmgren, Elena Ambrosino, Olivier Birot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunityMichela Spadaro, Elena Ambrosino, Manuela Iezzi, et al.
Oncoimmunology|July 9, 2015
Antitumor immunization of mothers delays tumor development in cancer-prone offspringGiuseppina Barutello, Claudia Curcio, Michela Spadaro, et al.
Oncotarget|December 10, 2017
Endogenous glutamine decrease is associated with pancreatic cancer progressionCecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, et al.
Journal of Cellular and Molecular Medicine|October 13, 2009
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathwayMarta Coscia, Elena Quaglino, Manuela Iezzi, et al.
The Journal of Clinical Investigation|April 17, 2003
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomasClaudia Curcio, Emma Di Carlo, Raphael Clynes, et al.
Pageof 7